Latest Breaking News On - Canale communications - Page 13 : comparemela.com

eFFECTOR Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update

10.05.2022 - Plan to present data at ASCO 2022 from ongoing zotatifin Phase 1/2 dose escalation and expansion trial Intend to provide an update on expanded development of zotatifin SAN DIEGO and REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) - eFFECTOR .

United statesLincoln parkStephanie carringtonSteve worlandHeidi chokeirEffector therapeutics incUniversity of texas md anderson cancer centerCanale communicationsExchange commissionDevelopment rd expensesUniversity of california san franciscoFirst in human phaseFunda meric bernstamDevelopmental therapeuticsMolecularly targeted agentsTumor biology

Patient Square Capital Announces the Formation of Enavate Sciences to Invest in and Support Therapeutic Companies

/PRNewswire/ Patient Square Capital ("Patient Square"), a leading dedicated health care investment firm, today announced the formation of a new portfolio.

Doug allen zach kouweJim momtazeeLeerink swannJames boylanIan stoneAccomplished health careMerrill lynchCanale communicationsEnavate sciencesBoard of directors enavate sciencesAccomplished health care executiveJoins enavateInitial investment commitment receivedSquare capitalPatient squareManaging partner

Kura Oncology to Report First Quarter 2022 Financial Results

27.04.2022 - SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) - Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report .

Roberth uhlCorporate communicationsCanale communicationsKura oncologyBreakthrough therapy designationVice presidentInvestor relations

Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1

Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United statesMassachusetts institute of technologyDburns mcclellanWilliam crowleySabrina martucci johnsonJake robisonLee rothRobert langerHormone therapy position statement advisory panelAmerican menopause societyBioscience incCanale communicationsHarvard medical schoolPrior phaseResults support potentialFirst monthly therapy

MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meetin

SAN DIEGO (BUSINESS WIRE) MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that two posters presenting preclinical data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 for zandelisib, an.

United statesKatie hurrishDavida walseyAmerican association for cancer researchDrug administrationCanale communicationsPharma incAmerican associationCancer researchAnnual meetingIntermittent dosing regimenPrivate securities litigation reform act